OSGSF yields 2.21% · JNJ yields 2.13%● Live data
📍 OSGSF pulled ahead of the other in Year 1
Combined, OSGSF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of OSGSF + JNJ for your $10,000?
Osaka Gas Co., Ltd. provides gas, electricity, and other energy products and services in Japan and internationally. It operates through four segments: Domestic Energy/Gas, Domestic Energy/Electricity, International Energy, and Life & Business Solutions. The Domestic Energy/Gas segment manufactures, supplies, sells, and maintains gas; engages in the gas piping works, call center operation, temporary staffing, various research and consulting, engineering and construction, leasing, installment payments assistance, energy service, and other activities, as well as insurance agency business; operates and maintains LNG terminals and power plants; supplies heat; and generates, sells, and maintains electricity. This segment also sells liquefied nitrogen, liquefied oxygen, and liquefied argon; gas appliances, and housing equipment and appliances; LNG and LPG; and others. The Domestic Energy/Electricity segment supplies electric power. It generates and sells electricity from natural gas, wind, biomass, and solar resources. The International Energy segment engages in the LNG transport; development and investment of petroleum and natural gas; investment relating to energy supply business; and energy supply business. The Life & Business Solutions segment manufactures and sells fine materials, carbon material products, activated carbon, wood protective coatings, absorbent functional materials, and resin additives; develops, leases, manages, and sells real estate properties; develops software products; and provides computer-based data processing services. This segment is also involved in the operation, management, and maintenance of buildings and facilities, and others. The company was founded in 1897 and is headquartered in Osaka, Japan.
Full OSGSF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.